Growth Metrics

Fulgent Genetics (FLGT) Current Assets (2016 - 2025)

Historic Current Assets for Fulgent Genetics (FLGT) over the last 11 years, with Q3 2025 value amounting to $507.4 million.

  • Fulgent Genetics' Current Assets rose 5537.93% to $507.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $507.4 million, marking a year-over-year increase of 5537.93%. This contributed to the annual value of $353.6 million for FY2024, which is 3037.82% down from last year.
  • Per Fulgent Genetics' latest filing, its Current Assets stood at $507.4 million for Q3 2025, which was up 5537.93% from $428.7 million recorded in Q2 2025.
  • Fulgent Genetics' Current Assets' 5-year high stood at $765.3 million during Q1 2022, with a 5-year trough of $326.5 million in Q3 2024.
  • In the last 5 years, Fulgent Genetics' Current Assets had a median value of $549.9 million in 2023 and averaged $537.4 million.
  • As far as peak fluctuations go, Fulgent Genetics' Current Assets surged by 168025.66% in 2021, and later plummeted by 4061.36% in 2024.
  • Fulgent Genetics' Current Assets (Quarter) stood at $612.0 million in 2021, then grew by 2.6% to $627.9 million in 2022, then dropped by 19.12% to $507.8 million in 2023, then plummeted by 30.38% to $353.6 million in 2024, then skyrocketed by 43.5% to $507.4 million in 2025.
  • Its Current Assets stands at $507.4 million for Q3 2025, versus $428.7 million for Q2 2025 and $416.8 million for Q1 2025.